To determine whether a difference in CD111 expression may have impacted the response of the tumor cell lines to M002, FACS analysis was used to determine the CD111 expression of several neuroblastoma cell lines, both MYCN amplified and non-amplified. This evidence concerns the gene MYCN and neoplasm.